Comparative study of tetranectin levels in serum and synovial fluid of patients with rheumatoid arthritis, seronegative spondylarthritis and osteoarthritis

Clinical Rheumatology

Volumn 17, Issue 4, 1998, Pages 318-324

  Kamper, E F ^a,b   Kopeikina, L T ^a   Trontzas, P ^a   Kyriazis, N Ch ^a   Vaiopoulos, G ^a   Stavridis, J ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Inflammatory markers; Osteoarthritis; Rheumatoid arthritis; Seronegative spondylarthritis; Serum and synovial fluid tetranectin

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 8; PROTEINASE INHIBITOR; TETRANECTIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FIBRINOLYSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SPONDYLOARTHROPATHY; SYNOVIAL FLUID LEVEL;

ADULT; AGED; ALPHA 1-ANTITRYPSIN; ALPHA-MACROGLOBULINS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BLOOD PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-8; LECTINS; LECTINS, C-TYPE; MALE; MIDDLE AGED; OSTEOARTHRITIS; SEROLOGIC TESTS; SPONDYLITIS, ANKYLOSING; SYNOVIAL FLUID;

EID: 0031666488     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01451013     Document Type: Article

References (37)

1. Hart DA, Fritzler MJ. Regulation of plasminogen activators and their inhibitors in rheumatic diseases: new understanding and the potential for new directions. J Rheumatol 1989;16:1184-91.
2. Haveman K, Gramse G. Physiology and pathology of neutral proteinases of human granulocytes. Adv Exp Med Biol 1984;84:1-20.
3. Kolev K, Komorowicz E, Owen WG, Machorich R. Quantitative comparison of fibrin degradation with plasmin, miniplasmin, neutrophil leukocyte elastase and cathepsin G. Thromb Haemost 1996;75:140-6.
4. Clemmensen I, Petersen LC, Kluft C. Purification and characterization of a novel oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin. Eur J Biochem 1986;156;327-33.
5. Holtet TL, Graversen JH, Clemmensen I, Thogersen HC, Etzerodt M. Tetranectin, a trimeric plasminogen-binding C-type lectin. Protein Science 1997; 6:1511-5.
6. Durkin ME, Naylor SL, Albreehtsen R, Wewer UM. Assignment of the gene for human tetranectin (TNA) to chromosome 3p22→p21.3 by somatic cell hybrid mapping. Cytogenet Cell Genet 1997;76:39-40.
7. Christensen L, Clemmensen I. Tetranectin immunoreactivity in normal human tissues. An immunohistochemical study of exocrine epithelia and mesenchyme. Histochemistry 1989; 92:29-35.
8. Hogdall CK, Christensen L, Clemmensen I. Tetranectin - a prognostic marker for carcinomas of the breast and ovary. Ugeskr Laeger 1994;156:6190-5.
9. Hogdall CK, Hogdall EVS, Hording V, et al. Plasma tetranectin and ovarian neoplasms Gynecol Oncol 1991;43:103-7.
10. Hogdall CK, Hording U, Norgaard-Pedersen B, Toftager-Larsen K, Clemmensen I. Serum tetranectin and CA-125 used to monitor the course of tetranectin in ovarian cancer patients. Eur J Obstet Gynecol Reprod Biol 1994;57:175-8.
11. Hogdall EVS, Hogdall CK, Clemmensen I, Norgaard-Pedersen B, Loft AGR. Tetranectin in amniotic fluid, maternal serum and fetal fluids. Scand J Clin Lab Invest 1991;51:411-5.
12. Kluft C, Jie AFH, Los P, E de Wit, Havekes L. Functional analogy between lipoproteins (a) and plasminogen in the binding to the kringle 4 binding protein tetranectin. Biochem Biophys Res Commun 1989;161:427-33.
13. Clemmensen I. Interaction of tetranectin with sulfated polysaccharides and trypan blue. Scand J Clin Lab Invest 1989;49:719-25.
14. Kluft C, Los P, Clemmensen I. Calcium-dependent binding of tetranectin to fibrin. Thromb Res 1989;55:233-8.
15. Fuhlendorff J, Clemmensen I, Magnusson S. Primary structure of tetranectin, a plasminogen kringle 4 binding plasma protein: homology with asialoglycoprotein receptors and cartilage proteoglycan core protein. Biochemistry 1987;26:6757-64.
16. Doege K, Fernandez P, Hassell JR, Sasaki M, Yamada Y. Partial cDNA sequence encoding a globular domain at the C terminus of the rat cartilage proteoglycan. J Biol Chem 1986; 261:8108-12.
17. Neame PJ, Young CN, Treep JT. Primary structure of a protein isolated from reef shark (Carcharhinus spingeri) cartilage that is similar to the mammalian C-type lectin homology, tetranectin. Protein Sci. 1992;1:161-8.
18. Kamper EF, Kopeikina LT, Koutsoukos V, Stavridis J. Plasma tetranectin levels and disease activity in patients with rheumatoid arthritis. J Rheumatol 1997;24:262-8.
19. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
20. Dougados M, van der Linden S, Juhlin H, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of Spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
21. Altman R, Asch E, Bloch D, et al. Development of criteria for classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986;29:1039-49.
22. Smith MD, Triantaphilou S, Parker A, Youssef PP. Coleman M. Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. J Rheumatol 1997;24:365-71.
23. Mancini G, Carbonara AO, Heremans JF. Immune chemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965;2:235-42.
24. Kushner I, Somervill JA. Permeability of human synovial membrane to plasma proteins: relationship to molecular size and inflammation. Arthritis Reum 1971;14:560-70.
25. Symons JA, Wong WL, Palladino MA, Duff GW. Interleukin 8 in rheumatoid and osteoarthritis. Scand J Rheumatol 1992;21:92-4.
26. Kopeikina L, Kamper E, Koutsoukos B, Stavridis J. The relationship between blood fibrinolytic potential and disease activity in rheumatoid arthritis. Clin Rheumatol 1997;16:1-6.
27. Matteson EL, Cohen MD, Conn DL. Clinical features of rheumatoid arthritis: systemic involvement. In: Klippel JH, Dieppe PA, editors. Practical rheumatology. London: Times Mirror International Publishers Ltd, Mosby, 1995:183-90.
28. Clemmensen I, Andersen BB. The fibrinolytic system and its relation to inflammatory diseases. Semin Arthritis Rheum 1982;11:90-8.
29. Harris ED Jr. Clinical features of rheumatoid arthritis. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, editors. Textbook of rheumatology, 4th edn. Philadelphia: WB Saunders, 1993:874-911.
30. Wallis WJ, Simkin RA, Nelp WB. Protein traffic in human synovial effusions. Arthritis Rheum 1987;30:57-63.
31. Shine B, Bourne JT, Baig FB, Dacte J, Doyle DV. C reactive protein and immunoglobulin G in synovial fluid and serum in joint disease. Ann Rheum Dis 1991;30:32-5.
32. Sitton NG, Dixon JS, Bird HA, Wright V. Serum biochemistry in rheumatoid arthritis, seronegative arthropathies, osteoarthritis, SLE and normal subjects. Br J Rheumatol 1987;26:131-5.
33. Borregaard N, Christensen L, Bjerrum OW, Birgens HS, Clemmensen I. Identification of a highly mobilizable subset of human neutrophil mtracellular vesicles that contains tetranectin and latent alkaline phosphatase. J Clin Invest 1990;85:405-15.
34. Clemmensen I, Lund LR, Christensen L, Andreasen PA. A tetranectin-related protein is produced and deposited in extracellular matrix by human embryonal fibroblast. Histochemistry 1991;195:735-41.
35. Velvart M, Fehr K. Degradation in vivo of articular cartilage in rheumatoid arthritis and juvenile chronic arthritis by cathepsin G and elastase from polymorphonuclear leukocytes. Rheumatol Int 1987;7:195-202.
36. Schalkwitjik J, Van den Berg WB, Van de Putte LBA, Joosten LAB. Elastase secreted by activated polymorphonuclear leukocytes causes chondrocyte damage and matrix degradation in intact articular cartilage: escape from inactivation by alpha-1-protease inhibitor Br J Exp Pathol 1987;68:81-8.
37. Kawabata K, Moore AR, Willoughby DA. Impaired activity of protease inhibitors towards neutrophil elastase bound to human articular cartilage. Ann Rheum Dis 1996;55:248-52.